# A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

> **NCT07699471** · PHASE3 · RECRUITING · sponsor: **MBX Biosciences** · enrollment: 160 (estimated)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **DRUG:** Canvuparatide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT07699471
- **Lead sponsor:** MBX Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-26
- **Primary completion:** 2028-01
- **Final completion:** 2029-08
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699471

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699471, "A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699471. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*